Pages Menu
Categories Menu

Posted by on Jul 10, 2014 in Cure News | 2 comments

Cure News: Week 7/10

doctor

 

Hey Everyone,

Two new tidbits for you:

1. Joshua Levy takes a deeper dive on several Artificial Pancreas projects, comparing and contrasting the progress made between them.

2. There’s been a lot of talk of re-programming liver cells to produce insulin, and this week Orgenesis signed an agreement with MaSTherCell in order to scale up liver cell production for phase 2 clinical trials. This is a good sign for how promising this path may be if a larger company is willing to help with production. Stayed tuned.

 

Until Next Time

-Nick

Thoughts? Comments?  Think we missed something? Please list any comments below!

(Special Thanks to Brian Braxton This Week)

2 Comments

  1. The JDCA is going against its own mission be continuously reporting on the AP as cure news. It does not meet one of your OWN criteria. Allowing a person to sleep worry free. Infusion sites can fall out and etc and the AP WILL fail and when it does if a person does not have supplies on hand they will be in trouble. Also I will say this until people stop considering it a cure. Will anyone with diabetes or trust a love one to go on an extended vacation with just the AP. No, the person will still have to take insulin and etc. It is only a treatment options. A cure means a person can move about freely with out worrying about it any more..ie not having to worry about vacation and saying oh I need to pack my insulin and other supplies just in case the AP FAILS.

    • I completely agree with Brian.We must’t worry about insulin, supplies. I want to forget to get anxious about my little son’s diabetes when he is at school or out.Artificial pancreas is only a good treatment. But we want a real cure

Post a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>